Grace Van Ness, MPH, CHES, Ann Thomas, MD, MPH & Sharon Vance

Slides:

Advertisements

Similar presentations

Presented by Cheri Booth, MPH MN Department of Health November 22, 2013.

Advertisements

African Americans and Hepatitis C

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.

Integration of Viral Hepatitis Prevention with STD Prevention: What Health Professionals Should Know Presenter: Jay Todd, Training and Public Education.

Epidemiology of STD, HIV and Hepatitis C among AI/AN Populations Melanie Taylor MD, MPH Centers for Disease Control and Prevention National STD Program,

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.

The Relationship Between Repeat Infections and Behavioral Risk Factors and Clinician Counseling: Findings from a Philadelphia STD Clinic M. Eberhart 1,

Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.

Hepatitis C Best Practice Guidelines Susan Thompson, RN, MPH September 2009.

Hepatitis C Rapid Antibody Testing Among At-Risk Populations, Arizona, 2014 Felicia McLean Public Health Associate Office for State, Tribal, Local and.

Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.

Adult Immunization 2010 Hepatitis B Vaccine Segment

‏Hepatitis B Eliminating Transmission Preventing Disease* John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention * The.

PREVENTING HIV AND OTHER STDs

Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.

Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,

Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.

HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.

A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.

Viral Hepatitis & Serving Seniors in Community Health Centers Corinna Dan, RN, MPH Office of HIV/AIDS and Infectious Disease Policy U.S. Department of.

Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.

Managing Hepatitis C: An Unprecedented Correctional Healthcare Challenge ASCA/CCHA meeting Phoenix, AZ RADM Newton E. Kendig Assistant Director/Medical.

Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.

Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.

Unmet Need for Hepatitis C PCR Testing, New York City, Emily McGibbon, MPH June 2011 CSTE Annual Conference.

Hepatitis B Virus 28.

Health Education Specialist

Overview National Hepatitis B Data

A Cluster of Hepatitis C among Rural, Young Adults – Illinois, 2012 Julia Howland, MPH CPH CDC/CSTE Applied Epidemiology Fellow Illinois Department of.

Sexually Transmitted Infections Mysheika Williams Roberts, MD, MPH Medical Director Assistant Health Commissioner Columbus.

Enhanced Hepatitis Strain & Surveillance System (EHSSS) in Review BCCDC Hepatitis Site Site Investigator: Liza McGuinness.

Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.

*Adjusted for underreporting. Source: National Notifiable Diseases Surveillance System (NNDSS)

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.

Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone:

Providing Comprehensive Reproductive Health Services for Men Visiting Clinics for Sexually Transmitted Infections Kees Rietmeijer, MD, PhD, MSPH Colorado.

Quarterly HIV/AIDS Analysis for Michigan January 1, 2008 Michigan Department of Community Health HIV/STD/Viral Hepatitis and TB Epidemiology Section Division.

Quarterly HIV/AIDS Analysis for Michigan July 1, 2006 Michigan Department of Community Health HIV/STD & Other Bloodborne Infections Surveillance Section.

Scioto County Medical Society Grand Rounds March 31, 2006 Portsmouth, Ohio Kathleen M. Koechlin, RN, MPH, PhD Hepatitis C Coordinator The Ohio Department.

2007 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.

2011 Viral Hepatitis Data. Data Limitations Morbidity based on reported positive lab result Morbidity based on reported positive lab result –Under-reporting.

HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.

TB, STDs, HIV, HEPATITIS C and SUBSTANCE ABUSE: A Local Perspective Paula Kriner, MPH Imperial County Public Health Department Management of TB, STDs,

The Swiss Population In 2001 Resident population: 7,258,500 Population density: 176 per Km 2 Foreign nationals: 20.1% (~1,460,000) Excess of births over.

Data Limitations Morbidity based on reported positive lab result –Under-reporting of both acute and chronic infections Morbidity based on CDC case definitions.

Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs.

Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.

High HIV, HBV and HCV Prevalence among People Who Inject Drugs: Results from the First Integrated Bio-behavioral Survey of PWID in Mozambique Authors:

Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.

| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.

Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,

Adult Hepatitis A and B Vaccination in Traditional and Non-Traditional Sites, North Carolina Beth Rowe-West, Head Immunization Branch Division of Public.

Source: National Notifiable Diseases Surveillance System (NNDSS)

Hepatitis C Virus Program in Chicago

Addressing Viral Hepatitis

Seroprevalence of Hepatitis B and C Markers among Inmates Entering the Nevada State Correctional System National Hepatitis Coordinators’ Conference, San.

Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2

Cascade of care for persons newly diagnosed

Hepatitis C Incidence and Prevalence in the U.S.

Treating Hep C with Novel Agents

Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D

Hepatitis C in the HIV-infected patient

FACTORS ASSOCIATED WITH RECEIPT OF HEPATITIS B VACCINE AMONG HIGH RISK ADULTS NATIONAL HEALTH INTERVIEW SURVEY, 2000 Nidhi Jain MD MPH The topic of my.

Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018

Hepatitis B Vaccination Assessment Adults Aged Years National Health Interview Survey, 2000 Gary L. Euler, DrPH1, Hussain Yusuf, MBBS2, Shannon.

Implementing New ACIP Adult Hepatitis B Vaccine Recommendations Eric E

Progress in Facilitating National HCV Prevention

M Javanbakht, S Guerry, LV Smith, P Kerndt

Lesson 3: Treatment as Prevention

Presentation transcript:

Grace Van Ness, MPH, CHES, Ann Thomas, MD, MPH & Sharon Vance

Background Hepatitis C virus (HCV) is the most common chronic blood-borne virus in the U.S. Morbidity and mortality related to HCV infection is predicted to increase dramatically in the decade Given the heavy burden of disease and limited funding available for surveillance in most jurisdictions, novel surveillance strategies are needed to characterize persons with confirmed chronic HCV reported to local health departments.

Methods In 2010, we faxed a data collection form to clinicians to obtain information on newly-reported persons with chronic HCV residing in Multnomah County, Oregon Form used to collect demographic characteristics, clinical histories and HCV risk factors

Methods Surveillance activity encompassed both presumptive and confirmed HCV+ cases Confirmed Case Definition Anti-HCV+ with s/co predictive of true value, or HCV RIBA+, or HCV RNA+, or HCV genotype results Presumptive Case Definition Anti-HCV+ without s/co ratio available

Fax Surveillance Tracking, Multnomah County, 2010

Source of HCV test results, Multnomah County, 2010 (N = 1342 faxed forms)

Sex of HCV+ cases by clinician response (N= 1342 faxed forms), Multnomah County, 2010

Age of HCV+ cases by clinician response (N= 1342 faxed forms), Multnomah County, 2010

Race of HCV+ Cases Multnomah County, 2010, (N = 913)

Reasons for HCV Testing, 1 Multnomah County, 2010 (N = 913) 1 Number and proportion, not mutually exclusive

Clinician-reported risk factors 1 of HCV+ cases, Multnomah County, 2010 (N = 913) Risk FactorNumber (%) History of injection drug use389 (42.6) Incarceration243 (26.6) Treated for sexually transmitted disease41 (4.5) Transfusion/Transplant prior to (0.9) Received clotting factors prior to (19.2) Medical or dental employee123 (2.5) History of dialysis1 (0.1) Men who have sex with men34 (3.7) Sexual contact with HCV+ partner39 (4.3) Household contact with HCV+ individual25 (2.7) No reason/No risk factor identified241 (26.4) Other 2 46 (5.0) 1 Number and proportion, not mutually exclusive 2 Tattoos, perinatal exposure, intranasal drug use

Access to Care and Preventive Services among HCV + cases, Multnomah County, 2010 Health indicatorNumber (%) Cirrhosis51 (5.6%) Referred to specialist390 (42.7%) Received HCV treatment70 (7.7%) Provided HCV education/literature/counseling541 (59.3%) Health insurance506 (55.6%) Received hepatitis A vaccine231 (25.3%) Received hepatitis B vaccine249 (27.3) 1 Number and proportion, not mutually exclusive 2 Tattoos, perinatal exposure, intranasal drug use 3 includes public and private insurance

Conclusions Given a relatively modest investment in resources (FTE = 1.25), MCHD was successful in capturing valuable risk factors and demographic information on newly-reported chronic HCV cases and describing their clients’ ability to access medical care and preventative services such as vaccination. Although this surveillance strategy needs validation and is limited in its ability to describe individuals without identifiable primary care providers, use of faxes to clinicians is worth further investigation as a surveillance tool when individual case investigation is not feasible.